Review
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Sep 28, 2023; 15(9): 256-273
Published online Sep 28, 2023. doi: 10.4329/wjr.v15.i9.256
Role of pulmonary perfusion magnetic resonance imaging for the diagnosis of pulmonary hypertension: A review
Miriam Lacharie, Adriana Villa, Xenios Milidonis, Hadeer Hasaneen, Amedeo Chiribiri, Giulia Benedetti
Miriam Lacharie, Oxford Centre of Magnetic Resonance Imaging, University of Oxford, Oxford OX3 9DU, United Kingdom
Adriana Villa, Department of Diagnostic and Interventional Radiology, German Oncology Centre, Limassol 4108, Cyprus
Xenios Milidonis, Deep Camera MRG, CYENS Centre of Excellence, Nicosia, Cyprus, Nicosia 1016, Cyprus
Hadeer Hasaneen, School of Biomedical Engineering & Imaging Sciences, King's College London, London WC2R 2LS, United Kingdom
Amedeo Chiribiri, School of Biomedical Engineering and Imaging Sciences, Kings Coll London, Div Imaging Sci, St Thomas Hospital, London WC2R 2LS, United Kingdom
Giulia Benedetti, Department of Cardiovascular Imaging and Biomedical Engineering, King’s College London, London WC2R 2LS, United Kingdom
Author contributions: Villa ADM was responsible for the review concept; Lacharie M drafted the manuscript; Lacharie M provided critical revision of the manuscript for important intellectual content; and all authors critically reviewed the content.
Conflict-of-interest statement: Authors declare no conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Miriam Lacharie, MSc, Researcher, Oxford Centre of Magnetic Resonance Imaging, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, Oxford OX3 9DU, United Kingdom. miriam.lacharie@cardiov.ox.ac.uk
Received: July 27, 2023
Peer-review started: July 27, 2023
First decision: September 4, 2023
Revised: September 16, 2023
Accepted: September 22, 2023
Article in press: September 22, 2023
Published online: September 28, 2023
Processing time: 61 Days and 16.5 Hours
Abstract

Among five types of pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH) is the only curable form, but prompt and accurate diagnosis can be challenging. Computed tomography and nuclear medicine-based techniques are standard imaging modalities to non-invasively diagnose CTEPH, however these are limited by radiation exposure, subjective qualitative bias, and lack of cardiac functional assessment. This review aims to assess the methodology, diagnostic accuracy of pulmonary perfusion imaging in the current literature and discuss its advantages, limitations and future research scope.

Keywords: Pulmonary perfusion MRI, Pulmonary hypertension, Dynamic contrast enhanced magnetic resonance imaging, Chronic thromboembolic pulmonary hypertension, Computed tomography pulmonary angiography, Chronic thromboembolic disease

Core Tip: Chronic thromboembolic pulmonary hypertension is an under-diagnosed disorder with high mortality if not diagnosed on time, however it can be fully cured with efficient diagnostic tools. Pulmonary perfusion magnetic resonance imaging (MRI) provides a non-invasive, reliable, radiation free and safer diagnostic test potentially replacing the standard techniques. Cardiopulmonary MRI also provides a comprehensive cardiopulmonary assessment in one single visit resulting in patients’ convenience and better utilization of healthcare resources and time.